Measles Frequently Asked Questions (FAQ)
|
Answers to frequently asked questions (FAQs) related to measles outbreaks and the latest vaccine recommendations, in downloadable, printable memorandum format.
|
May 20, 2019
|
|
Notes from the Field: Measles Outbreaks from Imported Cases in Orthodox Jewish Communities — New York and New Jersey, 2018–2019
|
Measles outbreaks in New York and New Jersey occurred after unvaccinated travelers reported recent travel to Israel, where a measles outbreak of more than 3,000 cases is ongoing.
|
May 20, 2019
|
|
Notes from the Field: Community Outbreak of Measles — Clark County, Washington, 2018–2019
|
A measles outbreak has affected dozens in Washington, and of approximately 3,800 contacts of infected patients, 22 percent lacked acceptable presumptive evidence of measles immunity.
|
May 20, 2019
|
| Vaccine Package Inserts |
The package insert for Shingrix shingles vaccine has been updated with information about immune system disorders, general disorders and administration site conditions. |
May 20, 2019
|
MMQC-19-1343 Yellow Fever Vaccine (YF-VAX) Resume Unrestricted Ordering
|
Ordering of yellow fever vaccine has resumed after shipments of vaccine were halted in April 2019.
|
May 20, 2019 |
| DHA-IHB Information Papers |
The information paper on Cold Chain Management of Measles, Mumps, Rubella Vaccine has been updated throughout. |
May 15, 2019 |
| CDC Pink Book Webinar Series |
Starting June 5, 2019, a webinar will be held each Wednesday on a different chapter of the Epidemiology and Prevention of Vaccine-Preventable Diseases ("Pink Book"). Registering for one webinar will automatically register you for the entire series. Check our education calendar for dates and times of each webinar. |
May 14, 2019
|
MMQC-19-1891 Disposition Instructions for 2018-2019 Influenza Virus Vaccine
|
In preparation for the upcoming 2019 -2020 influenza vaccine season, activities can follow this disposition guidance for influenza vaccine from the previous season.
|
May 14, 2019 |
|
Increase in Hepatitis A Virus Infections — United States, 2013–2018
|
During 2016–2018, reports of hepatitis A infections in the United States increased by 294% compared with 2013–2015, related to outbreaks associated with contaminated food items, among men who have sex with men, and primarily, among persons who report drug use or homelessness.
|
May 13, 2019 |
| Measles Frequently Asked Questions (FAQ) |
Answers to frequently asked questions (FAQs) related to measles outbreaks and the latest vaccine recommendations.
|
May 10, 2019 |
Vaccine Standing Orders
|
The standing order for the administration of Japanese encephalitis vaccine to children and adolescents has been updated with minor clarification on requirements and recommendations. |
May 9, 2019
|
|
Progress Toward Measles Elimination — European Region, 2009–2018
|
By end of 2017, 70 percent of European Region countries were verified to have eliminated endemic measles. During 2017–2018, however, a resurgence of measles occurred, with large-scale outbreaks in Ukraine, Serbia, and some countries that had achieved elimination.
|
May 6, 2019 |
| Vaccine package inserts |
The prescribing information for Boostrix Tdap vaccine has been updated with minor revisions. |
May 1, 2019 |
|
Preteens, teens target audience for HPV vaccine
|
The human papillomavirus (HPV) vaccine is almost 100 percent effective in preventing HPV infections, which eventually may cause several types of cancer.
|
April 29, 2019
|
|
Increase in Measles Cases — United States, January 1–April 26, 2019
|
A total of 704 cases of measles have been reported in the United States this year, the highest number reported since 1994. Outbreaks in underimmunized, close-knit communities accounted for 88 percent of all cases.
|
April 29, 2019 |
MMQC-19-1808 Yellow Fever Vaccine (YF-VAX) Ordering Restrictions & Inventory Requirements / Additional Guidance
|
The manufacturer of YF-VAX yellow fever vaccine has identified a packaging deviation issue, resulting in halt of YF-VAX shipments. There are no product quality, safety or efficacy concerns with the product itself. All activities must report on-hand inventory of YF-VAX vaccine no later than Saturday, May 4, 2019.
|
April 26, 2019 |